Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Aug 1;175(3):1383-7.
doi: 10.4049/jimmunol.175.3.1383.

Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis

Affiliations

Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis

Stacey L Wooden et al. J Immunol. .

Abstract

HLA-E is an MHC class Ib molecule that binds nonamer peptides derived from the leader sequence of MHC class 1a molecules and is the major ligand for CD94/NKG2 receptors found on NK and T cells. Using the MHC class Ia-null cell line 721.221, we find that surface HLA-E increases following heat shock at 42 degrees C and NK cell-mediated lysis is inhibited using heat-stressed 721.221 _targets. We have used mass spectrometry to identify and sequence a novel peptide from HLA-E following heat shock, ALALVRMLI, derived from the transmembrane domain of the human ATP-binding cassette protein, multidrug resistance-associated protein, MRP7. Pulsing 721.221 _targets with synthetic MRP7 peptide results in strong inhibition of NK cell-mediated lysis that is reversible using anti-CD94 and anti-class I mAbs. This report is the first to identify a non-MHC leader inhibitory peptide bound to HLA-E and provides insight into the immunoregulatory role of HLA-E during cell stress.

PubMed Disclaimer

Similar articles

Cited by

  • Stranger in a strange land.
    Hunt JS. Hunt JS. Immunol Rev. 2006 Oct;213:36-47. doi: 10.1111/j.1600-065X.2006.00436.x. Immunol Rev. 2006. PMID: 16972895 Free PMC article. Review.
  • HLA-E: a novel player for histocompatibility.
    Kraemer T, Blasczyk R, Bade-Doeding C. Kraemer T, et al. J Immunol Res. 2014;2014:352160. doi: 10.1155/2014/352160. Epub 2014 Oct 20. J Immunol Res. 2014. PMID: 25401109 Free PMC article. Review.
  • ABCC10, ABCC11, and ABCC12.
    Kruh GD, Guo Y, Hopper-Borge E, Belinsky MG, Chen ZS. Kruh GD, et al. Pflugers Arch. 2007 Feb;453(5):675-84. doi: 10.1007/s00424-006-0114-1. Epub 2006 Jul 26. Pflugers Arch. 2007. PMID: 16868766 Review.
  • CD8+ T cell _targeting of tumor antigens presented by HLA-E.
    Iyer RF, Verweij MC, Nair SS, Morrow D, Mansouri M, Chakravarty D, Beechwood T, Meyer C, Uebelhoer L, Lauron EJ, Selseth A, John N, Thin TH, Dzedzik S, Havenar-Daughton C, Axthelm MK, Douglas J, Korman A, Bhardwaj N, Tewari AK, Hansen S, Malouli D, Picker LJ, Früh K. Iyer RF, et al. Sci Adv. 2024 May 10;10(19):eadm7515. doi: 10.1126/sciadv.adm7515. Epub 2024 May 10. Sci Adv. 2024. PMID: 38728394 Free PMC article.
  • Variation in the ligand binding domains of the CD94/NKG2 family of receptors in the squirrel monkey.
    LaBonte ML, Russo J, Freitas S, Keighley D. LaBonte ML, et al. Immunogenetics. 2007 Oct;59(10):799-811. doi: 10.1007/s00251-007-0249-z. Epub 2007 Sep 25. Immunogenetics. 2007. PMID: 17896104

Publication types

MeSH terms

LinkOut - more resources

  NODES
twitter 2